| MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the Tumour (NCT03934827) | Imperial College London | 2019-04-10 |
| Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma (NCT03291028) | Fox Chase Cancer Center | 2017-11-27 |
| UC-GENOME: Urothelial Cancer-GENOmic Analysis to iMprove Patient Outcomes and rEsearch (NCT02643043) | Matthew Milowsky, MD | 2017-07-26 |
| Four Cycles Versus Six Cycles of Cisplatin-based Chemotherapy in Metastatic Urothelial Carcinoma (NCT03296306) | Asan Medical Center | 2016-09-01 |
| Integrated Cancer Repository for Cancer Research (NCT02012699) | University of Nebraska | 2013-11-01 |
| Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors (NCT01352962) | National Cancer Institute (NCI) | 2011-09-26 |
| Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer (NCT01191892) | Cardiff University | 2010-06-01 |
| Pazopanib Hydrochloride in Treating Patients With Metastatic Urethral Cancer or Bladder Cancer That Has Relapsed or Not Responded to Treatment (NCT01031875) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2009-12-01 |
| Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium (SUCCINCT) (NCT01089088) | Cardiff University | 2009-04-01 |
| Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium (NCT01090466) | Cardiff University | 2008-02-01 |
| Sunitinib in Treating Patients With Progressive Metastatic Transitional Cell Cancer of the Urothelium (NCT00397488) | Memorial Sloan Kettering Cancer Center | 2006-09-01 |
| Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer (NCT01118039) | Hospital del Mar | 2006-07-01 |
| Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants (NCT00900276) | Wake Forest University Health Sciences | 2006-06-01 |
| Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium (NCT00053209) | Eastern Cooperative Oncology Group | 2004-08-10 |
| S0400, FR901228 in Treating Patients With Advanced Cancer of the Urothelium (NCT00087295) | SWOG Cancer Research Network | 2004-06-01 |
| Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the Urothelium (NCT00082719) | M.D. Anderson Cancer Center | 2003-12-01 |
| S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy (NCT00066612) | SWOG Cancer Research Network | 2003-07-01 |
| Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant (NCT00082706) | M.D. Anderson Cancer Center | 2003-04-23 |
| S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium (NCT00045630) | SWOG Cancer Research Network | 2003-01-01 |
| S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium (NCT00055835) | SWOG Cancer Research Network | 2002-11-01 |
| Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium (NCT00080795) | M.D. Anderson Cancer Center | 2001-07-01 |
| S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract (NCT00022633) | SWOG Cancer Research Network | 2001-07-01 |
| Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer (NCT00022191) | European Organisation for Research and Treatment of Cancer - EORTC | 2001-05-01 |
| Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function (NCT00005644) | Eastern Cooperative Oncology Group | 2001-01-02 |
| Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium (NCT00014274) | European Organisation for Research and Treatment of Cancer - EORTC | 2001-01-01 |
| SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract (NCT00006351) | European Organisation for Research and Treatment of Cancer - EORTC | 2000-06-01 |
| Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract (NCT00006026) | European Organisation for Research and Treatment of Cancer - EORTC | 2000-05-01 |
| Combination Chemotherapy in Treating Patients With Bladder Cancer (NCT00003701) | Eastern Cooperative Oncology Group | 1999-04-02 |
| Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract (NCT00006111) | UNICANCER | 1999-04-01 |
| Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium (NCT00003376) | Eastern Cooperative Oncology Group | 1998-12-03 |
| Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer (NCT00003175) | Medical Research Council | 1997-12-01 |
| Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract (NCT00002914) | Eastern Cooperative Oncology Group | 1997-07-15 |
| Combination Chemotherapy in Patients With Advanced Urinary Tract Cancer (NCT00002684) | Memorial Sloan Kettering Cancer Center | 1995-05-01 |